Lexicon Pharma (LXRX) Shares Surge as Stifel Nicolaus Adds to 'Select List,' Boosts Price Target
Tweet Send to a Friend
Shares of Lexicon Pharma (NASDAQ: LXRX) have risen sharply Tuesday morning following some earlier optimism from Stifel Nicolaus' Stephen Willey ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
